Contraception as a Potential Gateway to Pre-Exposure Prophylaxis: US Women's Pre-Exposure Prophylaxis Modality Preferences Align with Their Birth Control Practices

Calabrese, Sarah K.; Galvao, Rachel W.; Dovidio, John F.; Willie, Tiara C.; Safon, Cara B.; Kaplan, Clair; Caldwell, Abigail; Blackstock, Oni J.; Phillips, Nicole; Kershaw, Trace

doi:10.1089/apc.2019.0242

Cited by 21 publications

(17 citation statements)

References 51 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…sexual and reproductive health services that use community engagement strategies to attract clients [ 1 •, 4 , 9 ]. Contraception provision and STI (sexually transmitted infections) testing has been described in numerous demonstration studies as the gateway to PrEP uptake and persistent use [ 8 , 21 , 22 ]. AGYW and people who engage in transactional sex especially prefer to obtain PrEP in clinic locations where they receive contraceptives as it may reflect comfort with trusted and familiar spaces [ 23 ].…”

Section: Mobile Clinicsmentioning

confidence: 99%

“…Currently, daily oral PrEP (either FTC/TDF: tenofovir disoproxil fumarate with emtricitabine; TDF/3TC: tenofovir disoproxil fumarate with lamivudine; or F/TAF: tenofovir alafenamide with emtricitabine) is the only PrEP modality approved by WHO and made available in countries with high HIV incidence [ 8 ]. WHO PrEP implementation tools stipulate that current PrEP program monitoring require individuals to interact with the healthcare system at least every 3 months for HIV testing and be provided with a supply of PrEP pills for up to 3 months [ 9 , 10 ].…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Novel Platforms for Biomedical HIV Prevention Delivery to Key Populations — Community Mobile Clinics, Peer-Supported, Pharmacy-Led PrEP Delivery, and the Use of Telemedicine

et al. 2021

View full text Add to dashboard Cite

Purpose of Review A gap exists between PrEP interest and PrEP uptake in key populations (KP) for HIV prevention that may be ascribed to PrEP delivery services not being acceptable. This review summarizes novel platforms for HIV prevention outside of the traditional health facilities environment. Recent Findings Mobile health clinics provide highly acceptable integrated, KP-focused services at convenient locations with the potential of high PrEP uptake. Telemedicine and health apps decongest health systems and allow for personal agency and informed decision-making on personal health. Pharmacy-led PrEP delivery provides de-medicalized, confidential PrEP services at extended hours in community locations, from trusted medical professionals. Peer-supported delivery encourages continued PrEP use. Summary Community-based, differentiated and de-medicalized PrEP delivery can address uptake and continued use barriers in key populations. Future research should assess scalability, cost-effectiveness and sustainability of these PrEP delivery platforms, as well as focus on ways to simplify PrEP provision.

show abstract

Section: Mobile Clinicsmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Novel Platforms for Biomedical HIV Prevention Delivery to Key Populations — Community Mobile Clinics, Peer-Supported, Pharmacy-Led PrEP Delivery, and the Use of Telemedicine

et al. 2021

View full text Add to dashboard Cite

show abstract

“…Seventy-three percent of articles ( n = 43) focused on demand-side issues. 9 , 10 , 11 , 20 , 24 – 61 The themes identified for the demand-side phase were as follows: (1) HIV risk and risk perception, (2) knowledge and attitudes toward PrEP, and (3) barriers and facilitators to PrEP use. Nine (15%) articles focused on supply-side issues.…”

Section: Resultsmentioning

confidence: 99%

US Black cisgender women and pre-exposure prophylaxis for human immunodeficiency virus prevention: A scoping review

Conley

Johnson

Bond

et al. 2022

Womens Health (Lond Engl)

View full text Add to dashboard Cite

Background: Black cisgender women in the United States experience a disproportionate burden of human immunodeficiency virus acquisition. Pre-exposure prophylaxis is an effective oral daily medication that reduces the risk of human immunodeficiency virus through sex by 99% when taken as prescribed. However, less than 2% of eligible Black cisgender women take pre-exposure prophylaxis. The purpose of this scoping review was to describe the types of research studies done in this area, gaps in knowledge, and potential areas of research needed to increase pre-exposure prophylaxis use among Black cisgender women in the United States. Methods: We conducted our search in MEDLINE (PubMed), Embase (Elsevier), CINAHL (EBSCOhost), PsycINFO (EBSCOhost), and Scopus (Elsevier) using a combination of keywords and database-specific subject headings for the following concepts: pre-exposure prophylaxis, African American/Black or minority, and women. We used the Joanna Briggs Institute’s Reviewers’ Manual process for Scoping Reviews and the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews to ensure comprehensive and standardized reporting of each part of the review. Results: Fifty-nine studies were included in the final review. Results of the study were classified according to the three phases of the Human Immunodeficiency Virus Prevention Cascade—demand side, supply side, and adherence and retention. The majority of studies ( n = 24, 41%) were cross-sectional quantitative surveys and 43 (34%) focused on the demand-side phase of the Human Immunodeficiency Virus Prevention Cascade. Fifty-eight percent of studies either assessed women’s pre-exposure prophylaxis knowledge, attitudes, and intentions to use, or assessed perceived barriers and facilitators. Seven studies (12%) tested pre-exposure prophylaxis uptake and adherence among Black cisgender women. Conclusion: This review found multiple missed opportunities to increase women’s demand for pre-exposure prophylaxis and health care provider screening and referral for pre-exposure prophylaxis. Additional studies are needed to effectively assess pre-exposure prophylaxis uptake and adherence among Black cisgender women.

show abstract

“…Black women may be more likely to take PrEP if provided education about and offered diverse forms of PrEP, which is consistent with existing literature. For example, one study found that women selected a form of PrEP based on ease of use and comfort [70]. Diversification of PrEP modalities and prioritization of those coinciding with popular contraception practices (e.g., pills, injections, and implants) may help to optimize PrEP acceptability and increase overall PrEP use among women.…”

Section: Fidelitymentioning

confidence: 99%

Mapping Implementation Science with Expert Recommendations for Implementing Change (MIS-ERIC): Strategies to Improve PrEP Use among Black Cisgender Women Living in Mississippi

Arnold

Whiteley

Elwy

et al. 2022

J. Racial and Ethnic Health Disparities

View full text Add to dashboard Cite

Background Blackwomen are disproportionately affected by the HIV epidemic. Strategies to increase Black women's use of pre-exposure prophylaxis (PrEP) are needed. Methods Interviews were conducted in Mississippi (MS) with Black, cisgender women at risk for HIV, and community healthcare clinic (CHC) staff who work directly with this population. Reflexive thematic analysis was used to identify barriers and select appropriate implementation strategies to increase PrEP care. Results Twenty Black women and twelve CHC staff were interviewed. PrEP use barriers resulted from low HIV risk awareness, lack of PrEP knowledge, and structural and stigma-related barriers. Methods for PrEP education and motivation included normalizing PrEP in public communications, providing education at places where women congregate, and tailoring PrEP content with Black women as educators. The Expert Recommendations for Implementing Change (ERIC) project provides a way for implementation scientists to select strategies that are consistent within research and practice across studies. Strategies from the ERIC project were selected to address implementation barriers. Conclusions Tailoring PrEP implementation protocols to increase Black women's access, engagement, and adherence to PrEP is needed. This is one of the first implementation studies to incorporate these four implementation concepts into a single study: (1) implementation outcomes, (2) i-PARIHS, (3) ERIC's strategy list, and (4) operationalizing the strategies using the Proctor et al., guidelines. Results provide an in-depth comprehensive list of implementation strategies to increase PrEP uptake for Black women in MS.

show abstract

Contraception as a Potential Gateway to Pre-Exposure Prophylaxis: US Women's Pre-Exposure Prophylaxis Modality Preferences Align with Their Birth Control Practices

Cited by 21 publications

References 51 publications

Novel Platforms for Biomedical HIV Prevention Delivery to Key Populations — Community Mobile Clinics, Peer-Supported, Pharmacy-Led PrEP Delivery, and the Use of Telemedicine

Novel Platforms for Biomedical HIV Prevention Delivery to Key Populations — Community Mobile Clinics, Peer-Supported, Pharmacy-Led PrEP Delivery, and the Use of Telemedicine

US Black cisgender women and pre-exposure prophylaxis for human immunodeficiency virus prevention: A scoping review

Mapping Implementation Science with Expert Recommendations for Implementing Change (MIS-ERIC): Strategies to Improve PrEP Use among Black Cisgender Women Living in Mississippi

Contact Info

Product

Resources

About